Improving kidney health in patients with chronic kidney disease through a systems biology approach.
A Systems Biology and Patient Stratification Approach to Improve Outcomes of Patients with Hypoxic Injury in Renal Tubular Cells in Chronic Kidney Diseases
This study is looking at how low oxygen levels affect kidney cells in people with chronic kidney disease, and it aims to create a helpful scoring system to better understand how these changes relate to patient outcomes, which could lead to improved treatments for those living with this condition.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10755642 on NIH RePORTER |
What this research studies
This research investigates how hypoxic injury affects renal tubular cells in patients with chronic kidney disease (CKD). By examining the role of Hypoxia Inducible Factor-1α (HIF-1α) and its impact on kidney tissue, the study aims to develop a scoring system that correlates HIF-1α activity with clinical outcomes. The approach includes identifying specific clinical and pathologic features that are associated with increased HIF-1α activity, which could lead to better patient stratification and targeted therapies. Ultimately, this research seeks to enhance understanding of CKD progression and improve treatment options for affected patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with chronic kidney disease who exhibit signs of tubular injury.
Not a fit: Patients with acute kidney injury or those without chronic kidney disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for chronic kidney disease, potentially improving patient outcomes and quality of life.
How similar studies have performed: Previous research has shown promise in targeting the HIF-1α pathway for treating kidney-related conditions, indicating potential for success in this approach.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Schaub, Jennifer Ann — University of Michigan at Ann Arbor
- Study coordinator: Schaub, Jennifer Ann
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.